
Aprocitentan
Non pwodwi: Aprocitentan
CAS: 1103522-45-7
MF: C16H14BR2N6O4S
MW: 546.19
Einecs:
MDL Non.:MFCD28155267
Pwopriyete
Aparans blan nan poud blan-blan
Pwen k ap fonn: 139-141 degre
Pwen bouyi: 7 0 5. 0 ± 70.0 degre
Dansite 1.841 ± 0. 06 g\/cm3
Depo tanperati. -20 degre
Aplikasyon:
Aprocentan se yon roman oral antihypertensive dwòg prensipalman itilize pou tretman an nan tansyon wo REFRACTORY. Aprocentan se yon endotelin doub (ET) A\/B reseptè (ETA\/ETB) antagonist ki egzèse efè antiipèrtansif pa anpeche obligatwa nan ET -1 nan ETA ak ETB reseptè
Sinonim:
Avocitentan
1103522-45-7
Eseye
Macitentan metabolit M6
N-[5- (4- Bromophenyl) -6- {2- [(5- bromopyrimidin -2- yl) Oxy] ethoxy} pyrimidin {{{
Sulfamide, n-(5- (4- bromofenil) -6- (2- ((5- bromo -2- pyrimidinyl) oxy) ethoxy) {{
N-(Bromophenyl)-(pyrimidinyl(oxy)ethoxy)pyrimidinyl diaminosulfirik
aprocitentanum
5- (4- Bromophenyl) -4- (2- (5- bromopyrimidin -2- yl) oxethoxy) {{6} (Sulfamyol)
Baj popilè: 1103522-45-7 Aprocitentan, Lachin 1103522-45-7 manifaktirè aprocitentan, founisè

